Search results
Which Vitamins Are Good For Arthritis?
Shape via Yahoo News· 5 days agoManage Arthritis Taking supplements can be hugely beneficial for someone with arthritis. But ultimately, they are only meant to supplement the ...
Arthritis Foundation Encourages Patients to Mark Arthritis Awareness Month by Sharing Words That...
Digital Journal· 4 days agoThis initiative also reminds the public about the devastating impact of arthritis and the ongoing need for research to find new treatments</ ...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks via Yahoo Finance· 1 day agoMedicines Agency (EMA) seeking approval for its immunology medicine, Tremfya, for two new...
FDA OKs High-Concentration of Adalimumab Biosimilar Cyltezo
Medscape· 3 days agoUnlike the low-concentration formulation of adalimumab-adbm, launched July 1, 2023, this high-concentration version has not yet been granted an interchangeability designation.
Psoriasis pain: Prevalence and how to manage it
Medical News Today· 4 days agoPeople may describe psoriasis pain as itchy, achy, or stinging, with the feeling varying from person to person. Strategies such as using distraction,...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx...
Morningstar· 7 days agoPomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX) and certain officers. The class action, filed in ...
Barrington Research Reaffirms Outperform Rating for Option Care Health (NASDAQ:OPCH)
ETF DAILY NEWS· 7 days agoBarrington Research restated their outperform rating on shares of Option Care Health (NASDAQ:OPCH –...
722 Shares in Amgen Inc. (NASDAQ:AMGN) Purchased by McAdam LLC
ETF DAILY NEWS· 3 days agoMcAdam LLC purchased a new position in Amgen Inc. (NASDAQ:AMGN – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities ...
AbbVie (NYSE:ABBV) Price Target Cut to $180.00 by Analysts at BMO Capital Markets
ETF DAILY NEWS· 5 days agoAbbVie (NYSE:ABBV – Free Report) had its price objective cut by BMO Capital Markets from $195.00 to $180.00 in a report published on Monday morning, Benzinga reports. A number of other analysts ...
Investors Purchase Large Volume of Bristol-Myers Squibb Put Options (NYSE:BMY)
ETF DAILY NEWS· 2 days agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) saw some unusual options trading on Wednesday. Investors bought 69,538 put options on the company. This represents an increase of 76% compared ...